The aim of this study was to evaluate the efficacy and safety of an anti-hypercholesterolemic agent containing Berberis aristata, Silybum marianum and monacolin K and KA in a sample of Caucasian patients at low cardiovascular risk according to Framingham score. The primary outcome was to evaluate the effects of this nutraceutical combination on lipid profile; the secondary outcome was to evalua...

The objective of the research is to design and evaluate bio compounds Berberis aristata (BCBA) compressed tablets in psoriasis treatment. BCBA dose 300 mg was into by employing microcrystalline cellulose (MCC) sodium starch glycolate (SSG) as superdisintegrant necessary excipients direct compression method. fourier transform infrared (FTIR) results depicts no incompatibility among drug excipien...

B.aristata (Berberidaceae), an important herbal drug of the Indian system of medicine, commonly known in vernacular as “Daruharidra”, is used as stomachic, astringent, antiperiodic, antipyretic, antidiabetic, in the treatment of jaundice and eye infections. Due to its excessive harvesting by Pharmaceutical/Ayurvedic industries, a near scarcity of this plant material made another species of Berb...

Cancer is a multifactorial disease and hence can be effectively overcome by a multi-constituently therapeutic strategy. Medicinal plant extracts represent a perfect example of such stratagem. However, minimal studies have been done till date that portray the effect of extraction techniques on the phyto-constituent profile of plant extracts and its impact on anticancer activity. In the present s...

Breast cancer is second most common in women and accounts for 23% of all occurring cancers in women. At present, more than 60% of the chemotherapeutic drugs are developed from plants and their derivatives, which can be used for development of anticancer drugs. An Indian barberry, Berberis aristata has been traditionally used for the treatment of inflammation, skin diseases, ulcers and cancers. ...